Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Gaia Cristina Ghedini, Roberto Ronca, Marco Presta & Arianna Giacomini. (2018) Future applications of FGF/FGFR inhibitors in cancer. Expert Review of Anticancer Therapy 18:9, pages 861-872.
Read now
Read now
Francesca Battaglin, Alberto Puccini, Rossana Intini, Marta Schirripa, Alessandra Ferro, Francesca Bergamo, Sara Lonardi, Vittorina Zagonel, Heinz-Josef Lenz & Fotios Loupakis. (2018) The role of tumor angiogenesis as a therapeutic target in colorectal cancer. Expert Review of Anticancer Therapy 18:3, pages 251-266.
Read now
Read now
Francesco Varone, Giacomo Sgalla, Bruno Iovene, Teresa Bruni & Luca Richeldi. (2018) Nintedanib for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on Pharmacotherapy 19:2, pages 167-175.
Read now
Read now
Saira Khalique & Susana Banerjee. (2017) Nintedanib in ovarian cancer. Expert Opinion on Investigational Drugs 26:9, pages 1073-1081.
Read now
Read now
Antonio Rossi, Tiziana Pia Latiano, Paola Parente, Cinzia Chiarazzo, Filomena Limosani, Gabriele Di Maggio & Evaristo Maiello. (2017) The potential role of nintedanib in treating colorectal cancer. Expert Opinion on Pharmacotherapy 18:11, pages 1153-1162.
Read now
Read now
Articles from other publishers (9)
Lei Pan, Fanqi Meng, Wei Wang, Xu-hao Wang, Hui Shen, Pengchen Bao, Jian Kang & Delei Kong. (2023) Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review. Frontiers in Immunology 13.
Crossref
Crossref
Juan Liu, Jingjing Gao, Aoli Wang, Zongru Jiang, Shuang Qi, Ziping Qi, Feiyang Liu, Kailin Yu, Jiangyan Cao, Cheng Chen, Chen Hu, Hong Wu, Li Wang, Wenchao Wang, Qingsong Liu & Jing Liu. (2022) Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours. Molecular Oncology 16:8, pages 1761-1774.
Crossref
Crossref
Paolo Cameli, Rosa Metella Refini, Laura Bergantini, Miriana d’Alessandro, Valerio Alonzi, Carlo Magnoni, Paola Rottoli, Piersante Sestini & Elena Bargagli. (2020) Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Yunjing Zhu, Xue Liang, Cong Lu, Yihan Kong, Xing Tang, Yu Zhang, Tian Yin, Jingxin Gou, Yanjiao Wang & Haibing He. (2020) Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorption. International Journal of Pharmaceutics 586, pages 119569.
Crossref
Crossref
Mingze Qin, Ye Tian, Xiao Han, Qi Cao, Shuaishuai Zheng, Chunyang Liu, Xia Wu, Lei Liu, Yangyang Meng, Xiaobo Wang, Haotian Zhang & Yunlei Hou. (2020) Structural modifications of indolinones bearing a pyrrole moiety and discovery of a multi-kinase inhibitor with potent antitumor activity. Bioorganic & Medicinal Chemistry 28:11, pages 115486.
Crossref
Crossref
Letizia Procaccio, Vera Damuzzo, Francesca Di Sarra, Alberto Russi, Federica Todino, Vincenzo Dadduzio, Francesca Bergamo, Alessandra Anna Prete, Sara Lonardi, Hans Prenen, Angelo Claudio Palozzo & Fotios Loupakis. (2019) Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies. Drug Safety 42:2, pages 159-179.
Crossref
Crossref
Chun-Yu Liu, Tzu-Ting Huang, Pei-Yi Chu, Chun-Teng Huang, Chia-Han Lee, Wan-Lun Wang, Ka-Yi Lau, Wen-Chun Tsai, Tzu-I Chao, Jung-Chen Su, Ming-Huang Chen, Chung-Wai Shiau, Ling-Ming Tseng & Kuen-Feng Chen. (2017) The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. Experimental & Molecular Medicine 49:8, pages e366-e366.
Crossref
Crossref
Shijing Jia & Kevin K. Kim. 2017. Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease. Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease
103
131
.
Soojung LeeJudee Grace E. NemeñoJeong Ik Lee. (2016) Repositioning Bevacizumab: A Promising Therapeutic Strategy for Cartilage Regeneration. Tissue Engineering Part B: Reviews 22:5, pages 341-357.
Crossref
Crossref